Merck Signs Seven-Year Clinical Collaboration with Decode; Buys $10M of Decode Stock | GenomeWeb

This article serves to correct the initial investment Merck made in Decode. Merck bought $10 million worth of Decode shares, not $145 million as originally reported.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.